Sina Djali has over 25 years of experience in drug and clinical development in various companies and academia. Currently he is the Head of Integrated Clinical and Operational Analytics in Enabling Business and Information Solutions. In this role Sina is responsible for implementing a data driven approach that qualitative analysis of quantitative using advanced analytical techniques. Previously he was Head of Risk management – Central Monitoring, where he was responsible for implementing Analytical Risk Based Monitoring within GCDO, amongst other positions. Prior joining Janssen R&D in 2015 he has held several positions in regulatory affairs and clinical QA departments at Wyeth and Aventis Pharmaceuticals.